PATRICK WAINRIGHT: Open Payments
NPI 1871809004 · FOLSOM, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 10 payments from 7 companies in 2025. Trend: 2023 $443 · 2024 $148 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Exact Sciences Corporation | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Kerendia, Wegovy, Rybelsus, Ozempic, Cologuard Collection Kit, GEMTESA, MOUNJARO, FARXIGA.
Industry payments across LA — which companies pay providers there.
